Market Research Logo

The 2016 World Market Forecasts for Imported Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins

The 2016 World Market Forecasts for Imported Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins

This report was created for strategic planners, international marketing executives and export managers whose primary concern is the world market for medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins for those firms serving the world via exports and foreign direct investment. It does so for the current year based on a variety of key historical indicators and econometric models.

In what follows, this report begins by summarizing the world exporter’s market for medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins. The total level of exports on a worldwide basis is based on a model that aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on supply-side dynamics, market shares by country of origin are then calculated across each country market. These shares lead to a volume of import values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that competitors (countries serving that market) are likely to receive this year. From these figures, world rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.


1 METHODOLOGY & EXECUTIVE SUMMARY
1.1 Our Approach
1.2 The World Market: Imported Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins in 2016
1.3 The World Market: Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins Export Supplies in 2016
2 AFRICA: MEDICAMENTS CONTAINING ANTIBIOTICS IN DOSAGE FORM OR RETAIL PACKINGS EXCLUDING PENICILLINS AND STREPTOMYCINS IMPORTS IN 2016
2.1 Executive Summary
2.2 Algeria
2.3 Botswana
2.4 Burundi
2.5 Cameroon
2.6 Cape Verde
2.7 Cote d'Ivoire
2.8 Egypt
2.9 Ethiopia
2.10 Ghana
2.11 Madagascar
2.12 Mali
2.13 Mauritania
2.14 Mauritius
2.15 Morocco
2.16 Mozambique
2.17 Namibia
2.18 Niger
2.19 Nigeria
2.20 Rwanda
2.21 Senegal
2.22 South Africa
2.23 Sudan
2.24 Togo
2.25 Uganda
2.26 Zimbabwe
3 ASIA: MEDICAMENTS CONTAINING ANTIBIOTICS IN DOSAGE FORM OR RETAIL PACKINGS EXCLUDING PENICILLINS AND STREPTOMYCINS IMPORTS IN 2016
3.1 Executive Summary
3.2 Brunei
3.3 Cambodia
3.4 China
3.5 Hong Kong
3.6 India
3.7 Indonesia
3.8 Japan
3.9 Malaysia
3.10 Maldives
3.11 Papua New Guinea
3.12 Philippines
3.13 Singapore
3.14 South Korea
3.15 Sri Lanka
3.16 Taiwan
3.17 Thailand
3.18 Vietnam
4 EUROPE: MEDICAMENTS CONTAINING ANTIBIOTICS IN DOSAGE FORM OR RETAIL PACKINGS EXCLUDING PENICILLINS AND STREPTOMYCINS IMPORTS IN 2016
4.1 Executive Summary
4.2 Albania
4.3 Austria
4.4 Belarus
4.5 Belgium
4.6 Bosnia and Herzegovina
4.7 Bulgaria
4.8 Croatia
4.9 Cyprus
4.10 Czech Republic
4.11 Denmark
4.12 Estonia
4.13 Finland
4.14 France
4.15 Georgia
4.16 Germany
4.17 Greece
4.18 Hungary
4.19 Iceland
4.20 Ireland
4.21 Italy
4.22 Kazakhstan
4.23 Latvia
4.24 Lithuania
4.25 Luxembourg
4.26 Macedonia
4.27 Malta
4.28 Moldova
4.29 Norway
4.30 Poland
4.31 Portugal
4.32 Romania
4.33 Russia
4.34 Slovakia
4.35 Slovenia
4.36 Spain
4.37 Sweden
4.38 the Netherlands
4.39 Ukraine
5 LATIN AMERICA: MEDICAMENTS CONTAINING ANTIBIOTICS IN DOSAGE FORM OR RETAIL PACKINGS EXCLUDING PENICILLINS AND STREPTOMYCINS IMPORTS IN 2016
5.1 Executive Summary
5.2 Argentina
5.3 Belize
5.4 Bolivia
5.5 Brazil
5.6 Chile
5.7 Colombia
5.8 Costa Rica
5.9 Ecuador
5.10 El Salvador
5.11 Guatemala
5.12 Guyana
5.13 Honduras
5.14 Mexico
5.15 Nicaragua
5.16 Paraguay
5.17 Peru
5.18 Uruguay
6 NORTH AMERICA & THE CARIBBEAN: MEDICAMENTS CONTAINING ANTIBIOTICS IN DOSAGE FORM OR RETAIL PACKINGS EXCLUDING PENICILLINS AND STREPTOMYCINS IMPORTS IN 2016
6.1 Executive Summary
6.2 Barbados
6.3 Bermuda
6.4 Canada
6.5 Dominica
6.6 Dominican Republic
6.7 Jamaica
6.8 the Bahamas
6.9 the United States
7 OCEANA: MEDICAMENTS CONTAINING ANTIBIOTICS IN DOSAGE FORM OR RETAIL PACKINGS EXCLUDING PENICILLINS AND STREPTOMYCINS IMPORTS IN 2016
7.1 Executive Summary
7.2 Australia
7.3 Fiji
7.4 New Caledonia
7.5 New Zealand
8 THE MIDDLE EAST: MEDICAMENTS CONTAINING ANTIBIOTICS IN DOSAGE FORM OR RETAIL PACKINGS EXCLUDING PENICILLINS AND STREPTOMYCINS IMPORTS IN 2016
8.1 Executive Summary
8.2 Armenia
8.3 Azerbaijan
8.4 Israel
8.5 Jordan
8.6 Kyrgyzstan
8.7 Lebanon
8.8 Oman
8.9 Pakistan
8.10 Turkey
8.11 Yemen
9 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
9.1 Disclaimers & Safe Harbor
9.2 ICON Group International, Inc. User Agreement Provisions

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report